Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Gene transference
>>
Phase 1
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
ezaladcigene resoparvovec
(VY-AADC) / Voyager
AAV-hTERT
/ Libella Gene Therap
VGR-R01
/ Beijing Tongren Hospital
FT-003
/ Frontera
GEN2
/ GenVivo
Retinostat
(OXB-201) / Oxford Biomedica
131-I Apamistamab/CAR T-cell
(Iomab-ACT) / Actinium
4D-110
/ 4D Molecular Therap, Roche
AAV1-gSG
/ Genethon
AAVrh.10CUhCLN2
/ Cornell University, National Institutes of Health
AXO-AAV-GM2
/ Roivant
Biostrophin
(rAAV2.5-CMV-minidystrophin) / Bayer
CRISPR/Cas9 modified human hematopoietic stem cell therapy
/ Allife Medical Science and Technology
CSL200
/ CSL Behring
GZ402663
/ Sanofi, AGTC
HMI-103
/ Homology Medicines
INXN-4001
/ Precigen
KB301
/ Krystal Biotech
KB408
/ Krystal Biotech
LPX EWS/FL1 T1
/ Gradalis
MazF gene therapy
/ Takara
RP-L401
/ Rocket Pharma
TN-201
/ Tenaya Therap
TN-401
/ Tenaya Therap
TSHA-120
/ Taysha Gene Therapies
Thalagen
(autologous CD34+ cells transduced with TNS9.3.55) / San Rocco Therap, Memorial Sloan-Kettering Cancer Center
VY-HTT01
/ Voyager, Sanofi
XT-150 intrathecal
/ Xalud Therap
humantakinogene hadenovec
(PCRX-201) / Pacira
